Episode 11

April 19, 2025

00:19:15

11: Mitochondrial Weakness: Targeting Dnmt3a-Mutant Clonal Hematopoiesis

Hosted by

Gustavo B Barra
11: Mitochondrial Weakness: Targeting Dnmt3a-Mutant Clonal Hematopoiesis
Base by Base
11: Mitochondrial Weakness: Targeting Dnmt3a-Mutant Clonal Hematopoiesis

Apr 19 2025 | 00:19:15

/

Show Notes

Nature Communications (2025) 16:3306 et al., Nature Communications - This study shows that Dnmt3a-mutant hematopoietic stem and progenitor cells (HSPCs) sustain elevated mitochondrial membrane potential and oxidative phosphorylation, creating a selective vulnerability that can be targeted with long-chain alkyl‑TPP molecules such as MitoQ to ablate mutant clonal advantage in mouse and human cells. Key terms: Dnmt3a, clonal hematopoiesis, mitochondrial membrane potential, MitoQ, oxidative phosphorylation.

Study Highlights:
Using a Dnmt3aR878H/+ mouse model and DNMT3A knockdown human HSPCs, the authors show mutant HSPCs have DNA hypomethylation-driven upregulation of oxidative phosphorylation genes, higher mitochondrial membrane potential (Δψm), and increased respiration. Elevated Δψm leads to greater accumulation of long-chain alkyl‑TPP molecules (MitoQ, d‑TPP) in mutant mitochondria. MitoQ and d‑TPP selectively reduce mitochondrial respiration, induce mitochondrial permeability transition and apoptosis in mutant HSPCs, and reduce their competitive advantage ex vivo and in vivo. Key phenotypes are conserved between mouse and human primary HSPCs, supporting translational relevance.

Conclusion:
Elevated mitochondrial membrane potential is a conserved, targetable vulnerability of DNMT3A-mutant HSPCs; long-chain alkyl‑TPP compounds selectively accumulate in mutant mitochondria to reduce respiration, induce mitochondrial apoptosis, and ablate clonal advantage.

QC:
This episode was checked against the original article PDF and publication metadata.
Scope: article metadata and core scientific claims from the narration, excluding analogies, intro/outro, and music.
Factual QC score: 10/10.
Metadata QC score: 10/10.
Supported core claims: 6.
Claims flagged for review: 0.
Metadata checks passed: 4.
Metadata issues found: 0.
QC result: Pass.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis

First author:
Nature Communications (2025) 16:3306

Journal:
Nature Communications

DOI:
10.1038/s41467-025-57238-2

Reference:
Nature Communications (2025) 16:3306. DOI: 10.1038/s41467-025-57238-2

License:
Creative Commons Attribution 4.0 International (CC BY 4.0)

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you’ll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/elevated-mitochondrial-membrane-potential-therapeutic-vulnerability-dnmt3a-ch

Other Episodes